Controlled release medicinal insect bite and sting patch
A technology for controlled release of drugs and mosquitoes, applied in the field of external medicine, can solve the problems of poor and short efficacy, easy to pollute clothes, etc., and achieve the effects of long-lasting drug efficacy, long-lasting effect, and improvement of pigmentation degree and scar formation rate.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0016] like figure 1 , figure 2 As shown, the controlled-release drug mosquito bite patch includes a base layer 4, an adhesive layer 1 disposed on the base layer 4, and a drug layer disposed on the base layer. The drug layer includes a controlled-release drug layer arranged in the middle of the upper surface of the base layer 4, and an antipruritic layer 2 arranged on the outer edge of the controlled-release drug layer. The controlled-release drug layer includes a sustained-release layer 3 disposed near the base layer 4 and an immediate-release layer 5 disposed on the sustained-release layer 3 .
[0017] Taking the circular base layer as an example, the diameter of the base layer is preferably set to 1.5 cm, the diameter of the controlled-release drug layer is 0.5 cm, and the outer edge of the antipruritic layer is 0.5 cm from the outer edge of the base layer. The particle size of the drug particles in the sustained-release layer is preferably 200-300 nm, and the particle s...
Embodiment 2
[0030] The difference between this embodiment and embodiment 1 is only the content of each component.
[0031] The immediate-release layer includes the following medicines in proportion by weight: 10 parts of sodium bicarbonate, 5 parts of antibiotics and 4 parts of transdermal agent.
[0032] The antibiotic is selected from one or a mixture of levofloxacin, mupirocin, clindamycin, furazolidone and polymyxin.
[0033] The transdermal agent consists of menthol, propylene glycol and azone in a weight ratio of 1:1:1.
[0034] The release layer includes the following medicines in proportion by weight: 20 parts of sodium bicarbonate, 6 parts of antibiotics, 3 parts of plasticizer, and 5 parts of transdermal agent.
[0035] The antibiotic is selected from one or a mixture of levofloxacin, mupirocin, clindamycin, furazolidone and polymyxin.
[0036] The plasticizer is selected from diethyl phthalate or / and dibutyl phthalate.
[0037] The transdermal agent consists of menthol, prop...
Embodiment 3
[0043] like image 3 As shown, the controlled-release drug mosquito bite patch includes a base layer 4 , an adhesive layer 1 disposed on the base layer, and a drug layer disposed on the base layer 4 . The drug layer includes an anti-itch layer 2 arranged in the middle of the upper surface of the base layer 4, and a controlled-release drug layer arranged on the outer edge of the anti-itch layer 2. The controlled-release drug layer includes a sustained-release layer 3 disposed near the base layer 4 and an immediate-release layer 5 disposed on the sustained-release layer 3 .
[0044] The immediate-release layer includes the following medicines in proportion by weight: 8 parts of sodium bicarbonate, 4 parts of antibiotics, and 3 parts of transdermal agents.
[0045] The antibiotic is selected from one or a mixture of levofloxacin, mupirocin, clindamycin, furazolidone and polymyxin.
[0046] The transdermal agent consists of menthol, propylene glycol and azone in a weight ratio o...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


